| Name | Title | Contact Details |
|---|
In 1995, after 35 years in the wholesale building material distribution business, Jerry Merrill founded All American Building Products. His primary goal was to service professional contractors with vinyl siding and windows. Jerrys vision was to be the preferred vendor by providing his customers with superior products, service and wisdom. Mr. Merrill considered it a high compliment when his customers referred to him as "their distributor." In 2000, with the assistance of Kirk Van Vleet, Jerry expanded by opening an office in Tulsa. This opening gave All American full coverage of Oklahoma. Mr. Van Vleet then opened a third location in Fort Smith, Arkansas, in the fall of 2007. Today, it is still our desire to continue with Jerrys vision and to be "Your Distributor." "It is our mission to be your preferred vendor by providing our customers with superior products, service, and wisdom. It is our highest compliment to be called your distributor."
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Franklin Products, inc. was founded in 1992 to fill a niche in the marketplace for high quality fluid bed dryer exhaust filters at highly competitive price points for the pharmaceutical industry. Successes in the pharmaceutical industry led to rapid growth into other industries such as food production and chemical manufacturing. All markets where the best quality product is required to do the job!